Concerns Over GLP-1 Weight Loss Drugs and Their Impact on Health

Have you noticed more faces that seem hollow, with defined cheekbones and sunken eyes around you lately?

Just look at the audience during the Grammys last Sunday—there were definitely a few more of those faces.

GLP-1 weight loss drugs have made their way into mainstream culture, not just viewed as medical aids but also as shortcuts to beauty.

By now, most people are aware that GLP-1 medications were initially designed for adults who are severely overweight or at risk for type 2 diabetes. Some of these users have multiple health issues.

These serious health problems can cause major disruptions in blood sugar regulation, leading to severe consequences like blindness, kidney failure, poor circulation, and even amputations.

For those in dire need, GLP-1s such as Ozempic, Mounjaro, and Wegovy can be lifesaving. However, there’s concern that they’ve shifted from a necessary solution to something more harmful when used outside their intended scope.

Interestingly, it’s not just sick or overweight individuals using these drugs anymore. The side effects range quite a bit, from mild to severe.

People are now, perhaps recklessly, risking various complications just for the sake of looks—it’s hard to ignore this truth.

Consider JoHelen McClain, a 72-year-old grandmother from Oklahoma. She started taking Wegovy in 2023, losing weight from 205 pounds down to 165. But in March 2024, while driving her granddaughter to a softball game, she heard a disturbing pop.

“My colon blew up. Literally blew up,” she recounted.

Then there’s Todd Engel, a 63-year-old man from Maryland who used Ozempic for diabetes management. After a few months, he claims he woke up one day unable to see from one eye. Nearly a year later, he lost vision in the other eye.

Both McClain and Engel are now part of lawsuits against the pharmaceutical companies, adding to a growing number of legal challenges asserting that these companies failed to fully disclose the risks of serious injuries associated with the medications.

The companies involved deny the allegations and plan to fight back legally. McClain, Engel, and others may find it challenging to prove that their health issues stemmed from the drugs they took—so who knows how it will unfold?

Such alarming stories might make healthy individuals reconsider taking GLP-1s for just a few extra pounds.

In January, a lawyer representing Novo Nordisk, the maker of Wegovy, revealed that a significant portion of federal lawsuits mention gastroparesis, a condition where the stomach stops processing food normally. This can lead to severe vomiting.

Another one in five cases mention issues with bowel muscle function. Additionally, 18% report experiences of intestinal blockage.

Is it truly worth the risk of such conditions just to fit into those jeans?

Now, there are also warnings that side effects may not only affect physical health but mental health as well.

Experts suggest that these GLP-1 drugs could revive dormant eating disorders or even create new ones. This really shouldn’t come as a shock.

Public health advocates have long attempted to dismantle a culture that idolizes extreme thinness—remember the ‘heroin chic’ of the 90s? It seems that kind of look is returning, but now it goes by “Ozempic chic.” And it requires a prescription.

But the complications don’t stop there.

Recent studies suggest that fast weight loss from GLP-1 drugs is linked to notable muscle loss, which can hurt metabolism and weaken bones—making individuals more susceptible to injuries.

Considering that falls are a leading cause of injury-related deaths among Americans over 65, it’s troubling that the medical community is leaning toward prescribing fragility.

Moreover, multiple analyses indicate that many users struggle to stop using GLP-1 medications without regaining the weight. This situation can lead to a lifetime reliance on these drugs. No thanks to that!

Here’s the reality: for healthy individuals, wellness doesn’t come from a needle.

Real and lasting health transformations stem from improving metabolic health, building and maintaining muscle, addressing mental health, and establishing sustainable habits.

Sure, it’s a slower process. It’s harder. And it doesn’t turn people into lifelong customers for pharmaceutical companies—perhaps that’s why those healthier paths are often overlooked.

Rather than investing heavily in marketing GLP-1 drugs to those without a specific medical need, wouldn’t it be better to focus on nutrition education, better access to fitness facilities, healing-oriented care, and early metabolic screenings? Imagine if the healthcare system encouraged genuine healing instead of merely treating symptoms indefinitely.

For anyone gazing at their reflection, pondering whether GLP-1s are the way to go, it’s essential to remember: Ozempic isn’t like taking an Advil. This is a potent medication that alters biology and may have serious physical and mental side effects.

No scale reading is worth compromising your muscle, mental health, or overall well-being.

If there’s a genuine medical reason for it, then by all means, use GLP-1s.

But in the wrong hands, these drugs aren’t solutions—they’re just another form of illness.